Skip to content

Home
Services
Find A Report
Media Corner
About Us
- About Spherix
- Join Our Team
Contact Us
Search for:

DMT Choice for Your MS Is Your Decision

From: Multiple Sclerosis News Today
By: Ed Tobias

DMT Choice for Your MS Is Your Decision

Spherix Global Insights2019-03-26T18:59:33+00:00

Related Posts

Biogen Drops After Piper Jaffray Downgrade, Price Target Cut

June 28, 2019
Biogen Stock Is Slipping Because a Multiple Sclerosis Drug Has Fierce Competition

June 28, 2019
Ocrevus Climbing as First-line DMT for RRMS Among Neurologists Surveyed in Spherix Report

September 21, 2018
Ocrevus Predicted to Be a Billion-dollar Blockbuster

September 4, 2018
Lupus Clinical Trials May Not Be Representative of Real-World Population, Report Suggests

August 1, 2018

US Headquarters

Spherix Global Insights

707 Eagleview Blvd
Suite 305
Exton, PA 19341

(484) 879-4284
[email protected]

EU Headquarters

Turmstrasse 28
6300 Zug
Switzerland

Join Our Newsletter

Leave this field empty if you're human:

Copyright 2017 © Spherix Global Insights US, Inc. All Rights Reserved

This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, visit About Cookies page.OK READ MORE